Table 1.
Group 1 |
Group 2 |
Group 3 |
Group 4 |
P Value | |
---|---|---|---|---|---|
Nonsnoring |
Snoring |
Mild OSA |
OSA |
||
AHI <1/h TST |
AHI <1/h TST |
AHI ≥1/h and <5/h TST |
AHI ≥5/h TST* |
||
(n = 90) | (n = 431) | (n = 348) | (n = 141) | ||
Age, yr | 6.86 (0.70) | 6.81 (0.70) | 6.82 (0.82) | 6.69 (1.02) | 0.480 |
Male sex, % | 56.67% | 54.99% | 53.16% | 56.03% | 0.899 |
Race | <0.001† | ||||
White, n | 67 (74.44%) | 273 (63.34%) | 200 (57.47%) | 48 (30.04%) | |
African American, n | 13 (14.44%) | 119 (27.61%) | 100 (28.74%) | 72 (51.06%) | |
BMI Z score | 0.46 (1.33) | 0.65 (1.26) | 0.73 (1.42) | 1.25 (1.53) | <0.001† |
Total sleep duration, min | 469.17 (47.74) | 472.62 (43.79) | 472.03 (48.07) | 460.21 (55.16) | 0.055 |
Sleep efficiency, % | 88.75 (8.09) | 89.25 (7.63) | 90.33 (7.54) | 89.63 (8.34) | 0.172 |
Stage 1, % | 7.31 (4.98) | 6.92 (4.90) | 6.59 (6.41) | 7.85 (6.48) | 0.239 |
Stage 2, % | 44.99 (7.81) | 45.87 (7.87) | 44.75 (8.56) | 44.38 (7.70) | 0.137 |
Stage SWS, % | 28.53 (6.83) | 26.05 (9.05) | 28.96 (9.24) | 26.30 (8.64) | 0.163 |
REM sleep, % | 24.43 (14.81) | 21.57 (8.78) | 20.56 (7.59) | 21.51 (13.93) | 0.059 |
Sleep latency, min | 26.52 (28.84) | 23.61 (24.04) | 20.93 (21.53) | 18.04 (21.60) | 0.023 |
REM latency, min | 147.86 (66.37) | 141.51 (59.24) | 150.22 (68.53) | 146.71 (67.62) | 0.300 |
Obstructive AHI, events/h TST | 0.40 (0.34) | 0.40 (0.29) | 2.11 (1.03) | 14.87 (12.44) | <0.001† |
SpO2 nadir,‡ % | 93.80 (2.35) | 92.72 (6.00) | 90.27 (5.00) | 82.65 (10.94) | <0.001† |
Total arousal index, events/h TST | 8.56 (3.95) | 9.14 (5.77) | 10.78 (7.39) | 17.51 (11.24) | <0.001† |
Asthma, % | 14.94 | 20.45 | 19.04 | 24.71 | 0.430 |
Definition of abbreviations: AHI = apnea–hypopnea index; BMI = body mass index; OSA = obstructive sleep apnea; SpO2 = oxygen saturation as measured by pulse oximetry; SWS = slow-wave sleep; TST = total sleep time.
AHI measured as number of events per hour of total sleep time.
Comparison is significant following Bonferroni’s correction.
SpO2 nadir refers to lowest levels of arterial oxygen saturation in the blood.